Cherwell Laboratories Introduces the ImpactAir ISO-90 Monitoring Platform
The new device is a modular system made to integrate into isolators or RABS, using an external controller and remotely located air mover.
Cherwell Laboratories, an environmental monitoring and process validation solutions supplier based in the United Kingdom, will unveil the new ImpactAir ISO-90 Monitoring Platform, a modular system made to integrate into isolators or restricted access barrier systems (RABS), using an external controller and remotely located air mover, according to an Oct. 29, 2019 press release.
The new model can be constructed in almost any orientation using standard or custom-made connections, according to the release. It comes equipped with a chamber for 90-mm agar plates and a slit-to-agar sampling method for efficient results. Additionally, the low D50 value and long sampling period makes the device suitable for continuous monitoring.
“We are really excited about the latest developments from Pinpoint and feel the ImpactAir ISO-90 will address a key requirement within pharma EM [environmental monitoring],” said Andy Whittard, managing director at Cherwell, in the press release. “That is to achieve higher sample volume within grade A environments and minimize risk in these critical zones. Further developments to the ISO-90 range promise to make installation within existing facilities easy.”
The company will present the new platform at Pharmig’s 27th Annual Conference from Nov. 13–14 at the Nottingham Belfry Hotel in the United Kingdom.
Source: Cherwell Laboratories
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact
April 16th 2025On April 14, 2025, the Trump Administration launched a national security-driven investigation into pharmaceuticals, a move that will likely result in tariffs being placed on pharmaceutical drugs, ingredients, and other components that are imported from outside of the United States.
